CoChat

Metabonomic Understanding of Probiotic Effects in Humans With Irritable Bowel Syndrome

Hong, Young-Shick, Hong, Kyoung Sup, Park, Min-Hwa, Ahn, Young-Tae, Lee, Jung-Hee, Huh, Chul-Sung, Lee, Jaekyung, Kim, In-Kyoung, Hwang, Geum-Sook, Kim, Joo Sung · 2011 · Journal of Clinical Gastroenterology
Cited by 63

The DOI matches its Crossref record.

Abstract

GOALS: This study was undertaken to evaluate the effects of probiotics on adult patients with irritable bowel syndrome (IBS) through clinical parameters and H nuclear magnetic resonance (NMR)-based metabonomics. BACKGROUND: As systematic effect of probiotics on inflammatory bowel disease through metabonomics approach has been extensively studied to date, metabonomic characterization of the probiotics effect on IBS is also needed for better understanding the effect with respect to host metabolic mechanism. STUDY: Seventy-four IBS patients meeting Rome criteria were randomized to receive probiotics and placebo through a parallel-group, double-blind, randomized, placebo-controlled clinical study. Probiotic fermented milk and placebo were administered 3 times daily for 8 weeks. Improvements of IBS were assessed according to Rome III questionnaires and H NMR metabolic profiling of serum and fecal samples from all participants was used to characterize a significant change in serum and fecal metabolome before and after probiotics. RESULTS: Fecal counts of the Lactobacilli, but not Bifidobacteria species, which included in the probiotic milk, were increased significantly in feces of IBS patients receiving treatment (P=0.014). NMR data set coupled with multivariate statistical analysis identified intrinsically elevated serum levels of glucose (P=0.0265) and tyrosine (P=0.0016) in IBS patients. These levels normalized to those of healthy individuals in the probiotic administration group, but not the placebo group. CONCLUSIONS: This metabonomic study suggests that in a subset of IBS patients there exists a potential dysregulation in energy homeostasis (serum glucose) and liver function (serum tyrosine) that may be improved through probiotics supplementation. Moreover, global metabolic profiling highlights the potential of metabonomic approach for assessing bowel diseases or symptoms with respect to host metabolic perturbation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mcg.0b013e318207f76c

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 63

Metadata

Authors
Hong, Y.-S., Hong, K. S., Park, M.-H., Ahn, Y.-T., Lee, J.-H., Huh, C.-S., Lee, J., Kim, I.-K., Hwang, G.-S., & Kim, J. S.
Venue
Journal of Clinical Gastroenterology
Published
2011-05
Volume
45
Issue
5
Pages
415-425
ISSN
0192-0790 (ISSN-L)
OpenAlex
W1964675346
Cited by
63
References
0
FWCI
5.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabonomic Understanding of Probiotic Effects in Humans With Irritable Bowel Syndrome. https://app.cochat.ai/papers/10.1097/mcg.0b013e318207f76c
The paper
Hong, Y.-S., Hong, K. S., Park, M.-H., Ahn, Y.-T., Lee, J.-H., Huh, C.-S., Lee, J., Kim, I.-K., Hwang, G.-S., & Kim, J. S. (2011). Metabonomic Understanding of Probiotic Effects in Humans With Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0b013e318207f76c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.